SS Innovations International (SSII) Cash from Operations Growth (3y) (2019 - 2026)
SS Innovations International (SSII) Cash from Operations Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 0.50% |
| 10 | SS Innovations International | 780.11 Mn | 756.50 Mn | 5.33 Mn | 2.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37% |
| Dec 31, 2025 | 18.80% |
| Sep 30, 2025 | -55.77% |
| Jun 30, 2025 | -45.49% |
| Mar 31, 2025 | -369.68% |
| Dec 31, 2024 | -205.30% |
| Sep 30, 2024 | -180.60% |
| Jun 30, 2024 | -166.14% |
| Mar 31, 2024 | -223.54% |
| Dec 31, 2023 | -805.34% |
| Sep 30, 2023 | -646.69% |
| Jun 30, 2023 | -417.76% |
| Mar 31, 2023 | -266.79% |
| Dec 31, 2022 | -187.08% |
| Sep 30, 2022 | -131.62% |
| Jun 30, 2022 | -210.54% |
| Mar 31, 2022 | 18.22% |
| Dec 31, 2021 | -6.66% |
| Sep 30, 2021 | -2.67% |
| Jun 30, 2021 | 23.72% |